The Consolidated Appropriations Act, signed into law on February 3, 2026, avoided another government shutdown. But notably for the US Food and Drug Administration (FDA) and drug developers, it also codified FDA’s long-standing approach toward the scope of orphan drug exclusivity that had become a subject of litigation in recent years. The Orphan Drug Act of 1983 was intended to incentivize the development of drugs for rare diseases.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Natasha
Contact Natasha, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack